Crown Laboratories Extension of Tender Offer to Acquire Revance Therapeutics, Inc.
Press Releases
Crown Laboratories, Inc.  
January 13, 2025

Crown Laboratories Extension of Tender Offer to Acquire Revance Therapeutics, Inc.

JOHNSON CITY, Tenn., Jan. 13, 2025 /PRNewswire/ -- Crown Laboratories, Inc. ("Crown"), a privately held, global innovative leader in the skincare industry, today announced that, at the request of Revance

avatar profile Olean Times Herald

Olean Times Herald


Local & Social